Markets

Insider Trading

Hedge Funds

Retirement

Opinion

QUALCOMM Incorporated (QCOM): Among Morgan Stanley’s Top Humanoid Robot Stock Picks

We recently compiled a list of the $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against the other humanoid robot stocks.

If there’s one thing that can be said for sure, it’s that 2024 is the year of technology. Artificial intelligence, despite its biggest detractors claims, has managed to persist, and in its wake, it has spurred new life into a variety of industries.

One such industry is robotics. Like artificial intelligence, robots have typically been thought to lie in the domain of science fiction. And like AI, they’re also becoming a reality faster than we can comprehend. One of the biggest advancements in robotics has been made by the private company Boston Dynamics, whose robot dogs are used by a lot of industrial customers, including SpaceX.

However, while Boston Dynamics’ robot dogs are impressive, humanoid robots, or those that look like humans and perform mechanical functions like humans are further in the domain of science fiction. These robots are popularized through movies such as. the Terminator series and iRobot, are in fact, a multi trillion dollar opportunity if we’re to believe research from Wall Street analysts.

A research report by Morgan Stanley that takes one of the most optimistic takes on humanoid robots speculates that by 2030, the humanoid population will sit at a comfortable 40,000. If this was impressive, the estimates for 2040 and 2050 are not only stunning but also orders of magnitude higher. By 2040 and 2050, the humanoid population could sit at an unbelievable 8 million and 63 million, respectively – or higher than 27 out of the 50 most populous countries in the world in 2024. In terms of monetary figures, the wage impact of the 8 million population is estimated to sit at a cool $357 billion, while the impact of the 63 million robots is $3 trillion.

This research builds on the total addressable markets for industries that are an indispensable part of the world but suffer from low labor due to low funding and wages and dangerous, repetitive, and boring tasks. A total of 21 such industries are identified, and they are divided into three tiers. The first tier, or Tier 1, is expected to see humanoid adoption as soon as 2028. In terms of the total adoption percentage, i.e. the number of roles in these industries that could be filled by humanoid robots, the top four industries are construction and extraction, production, farming, fishing, and forestry, and building and grounds clearing maintenance.

The risky industries highlighted above have an adoption potential of 70%, 68%, 67%, and 67%, respectively. The highest potential of the monetary impact is also from the Tier 1 industries, and it’s quite low if we’re to look at the ‘near term.’ For the years 2030, 2032, 2034, 2036, and 2038, the wage impacts sit at $1 billion, $6 billion, $19 billion, $60 billion, and $158 billion, respectively for the Tier 1 industries. The impact for Tier 2 industries starts in 2040, with Tier 4 beginning its contribution in 2044. Yet, while their adoption might be in the future, the riskiest of use cases, i.e. space exploration, has already seen a humanoid robot in the form of NASA’s Robonaut occupy the International Space Station (ISS) from 2011 to 2018. NASA’s Robonaut first made its way to space in 2011, and it was upgraded to Robonaut 2 in 2014 which was brought back to Earth in 2018.

One industry that MS is quite optimistic about when it comes to humanoids is social care. It believes that social care “is arguably the world’s largest TAM by the end of the century, but one that suffers from restrictive funding creating a lack of incentivisation to recruit or re-skill workers. Humanoids will face many challenges. And while they may not be the best solution, they are an increasingly necessary solution for a world facing immense longevity challenges.” Yet, the demand for these challenges could take its time to materialize. “Understanding the humanoid theme requires a multi-sector approach and a long term time horizon” cautions MS, but it wants investors to be ready to pounce on ” an extraordinary number of developments and milestones over the next 6 to 12 months” even though the “he path to commercialization at scale may take decades to fully play out.”

Talking numbers, there are a plethora of estimates floating around that wager a guess at the potential value of the humanoid robot industry. One estimate comes from no one else than the electric vehicle billionaire Elon Musk. Musk’s love of everything technology has made him who he is today, and it also means that he is often at the leading edge of leading technologies,  whether they are artificial intelligence, brain implants, or humanoid robots.

His most recent comments about humanoid robots came during his car company’s annual shareholder meeting. At the event, the executive shared that by selling these robots, his company could become worth a whopping $25 trillion at an unspecified time in the future. Musk’s robot is called Optimus, and his firm also believes that while the robot’s initial bill of materials (BOM) can range between $50,000 to $60,000, these costs can be brought down to enable his company to sell $1 trillion worth of robots a year.

Musk isn’t the only one who is convinced of the potential offered by humanoid robots. Research from more Wall Street analysts estimates that the market could be worth $38 billion by 2035. Mind you, this is the Goldman analysts’ base case model which estimates unit shipments of 1.4 million. The bear case, which sees shipments cut in half to 703 million suggests a value of $19 billion by 2035, while the bull case and the blue sky scenario estimate shipments of 6.5 million and 11.6 million units, respectively. Extrapolating from a $38 billion valuation that stems from 1.4 million units, this could mean that the very best scenario for the humanoid robot market leads to a value of $315 billion. At the heart of this optimism are AI and dropping BOM costs.

According to the analysts, the BOM for making humanoid robots has dropped by a strong 40% between 2023 and 2024 to range between $30,000 to $150,000 depending on the specifications. This reduction is primarily “driven by the availability of cheaper components with a broader scope of supply chain options from the mere existence in labs previously, optimization in design and manufacturing technique (e.g. cost for T-screw dropped significantly by shifting from electric discharge machining to mechanical machining.”

Our Methodology

To make our list of the best humanoid robot stocks to buy, we started with Morgan Stanley’s Humanoid 66 stock list. This list is divided into three categories, humanoid enablers and beneficiaries, enablers, and beneficiaries. Since the enablers are the ones that will directly benefit in terms of tangible revenues from potential growth in the humanoid industry, we selected the top 15 stocks in the first two categories.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A technician testing the latest 5G device, demonstrating the company’s commitment to innovation.

QUALCOMM Incorporated (NASDAQ:QCOM)

Number of Hedge Fund Investors  in Q1 2024: 78

QUALCOMM Incorporated (NASDAQ:QCOM) is one of the biggest semiconductor designers in the world. It designs and sells a variety of chips such as application processors, GPUs, modems, and others for smartphones and other use cases. QUALCOMM Incorporated (NASDAQ:QCOM) also enjoys a key advantage in the signals and image processing industries. These products are key for humanoid robots, and QUALCOMM Incorporated (NASDAQ:QCOM)’s decades of experience in the semiconductor design industry provide it with key advantages when compared to other firms. Additionally, it also has key licensing agreements that force companies to only use its products in regions such as the US. This adds to QUALCOMM Incorporated (NASDAQ:QCOM)’s competitive moat to ensure it can generate not only direct sales revenue but also recurring licensing revenue.

Aristotle Capital Management mentioned QUALCOMM Incorporated (NASDAQ:QCOM) in its Q2 2024 investor letter. Here is what the firm said:

Qualcomm, a leading wireless communications technology company, was the largest contributor for the quarter. After a period of weaker global demand for smartphones (driven by a slowdown in China) and elevated channel inventory, demand from Chinese handset manufacturers accelerated 40% year‐over‐year. More importantly, in our opinion, Qualcomm continues to execute on a previously identified catalyst of shifting its business mix beyond smartphones. The company announced increased progress for its automotive and Internet of Things (IoT) solutions. Within auto, the increase in vehicle content has resulted in 35% year‐over‐year revenue growth, with a design win pipeline of ~$45 billion, keeping the company on track to achieving ~$4 billion in auto‐related revenues by 2026. In recent years, despite persistent threats of insourcing from large clients (most notably Apple), Qualcomm has been able to retain its high market share in handsets while simultaneously expanding in non‐smartphone devices. We believe this progress is a testament to Qualcomm’s history of high (and productive) R&D spending, resulting in technological superiority. We believe Qualcomm’s technologies will continue to benefit as the world stays on a path toward a proliferation of connectivity between varying devices and as AI applications extend from the cloud to on‐device.”

Overall QCOM ranks 10th on our list of the best humanoid robot stocks to buy. While we acknowledge the potential of QCOM as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than QCOM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…